Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02550431 · ClinicalTrials.gov registry record
Trans Health: Evaluation of Markers of Cardio-metabolic Health and Well-being in Transgender Youth
A clinical trial of Transgendered Persons, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 58
- Enrollment target
- 1
- Study location
NCT02550431: Completed study of Transgendered Persons, sponsored by University of Colorado, Denver.
NCT02550431 is a study of Transgendered Persons that has completed, run by University of Colorado, Denver. The registered enrollment target is 58 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02550431, a study of Transgendered Persons, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 58 participants
- Enrollment target
- 1
- Study location
Study Summary
This study plans to learn more about puberty blockers and cross (testosterone and estradiol). There is not much known about how these medications affect hormone levels, heart health and overall general health in young transgender individuals.
Conditions Studied
Study Locations (1)
Colorado
- Children's Hospital Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2016-03 |
| Est. Completion | 2018-01-26 |
What the finished NCT02550431 record still lists
NCT02550431 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 58 participants, a relatively small participant target.
The record links to 1 condition, with Transgendered Persons appearing as the primary indexed condition, and to 0 interventions.
NCT02550431 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT02550431 about?
NCT02550431 is a clinical study titled "Trans Health: Evaluation of Markers of Cardio-metabolic Health and Well-being in Transgender Youth". This study plans to learn more about puberty blockers and cross (testosterone and estradiol). There is not much known about how these medications affect hormone levels, heart health and overall general health in young transgender individuals.
What is the current status of trial NCT02550431?
This trial is currently completed. The enrollment target is 58 participants. The study started on 2016-03. Estimated completion is 2018-01-26.
What conditions does trial NCT02550431 study?
This clinical trial studies the following conditions: Transgendered Persons.
Who is sponsoring clinical trial NCT02550431?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02550431 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia